Published: 26 August 2017
Author(s): Thibault Comont, Guillaume Moulis, Olivier Parant, Hélène Derumeaux, Odile Beyne Rauzy
Issue: August 2017
Section: Letter to the Editor

Immune thrombocytopenia (ITP) is the most common autoimmune cytopenia. This disease often occurs in young women [1]. Pregnancy is a well-known risk factor for developing newly diagnosed ITP as well as for inducing disease flares in patients with chronic ITP [2]. Severe bleeding is rare but a therapeutic intervention is needed for one third of the pregnant patients, mostly before delivery to allow peridural analgesia [3,4]. However, the impact of pregnancy in women with an old history of ITP, considered as cured, has not been assessed.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.